The price of Hims & Hers Health Inc (NYSE: HIMS) closed at $13.22 in the last session, down -5.30% from day before closing price of $13.96. On the day, 5284441 shares were traded.
Ratios:
We take a closer look at HIMS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.28. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 3.00. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on April 10, 2024, initiated with a Buy rating and assigned the stock a target price of $20.
On February 28, 2024, Imperial Capital Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $16.
On February 26, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $10.Leerink Partners initiated its Market Perform rating on February 26, 2024, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 08 ’24 when Baird Melissa sold 11,751 shares for $14.74 per share. The transaction valued at 173,254 led to the insider holds 538,932 shares of the business.
Baird Melissa sold 11,751 shares of HIMS for $171,372 on Apr 05 ’24. The Chief Operating Officer now owns 538,932 shares after completing the transaction at $14.58 per share. On Apr 04 ’24, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 188,888 shares for $14.97 each. As a result, the insider received 2,828,075 and left with 0 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.25 while its Price-to-Book (P/B) ratio in mrq is 8.20.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $17.16, while it has fallen to a 52-week low of $5.65.
Shares Statistics:
A total of 205.10M shares are outstanding, with a floating share count of 139.59M. Insiders hold about 34.85% of the company’s shares, while institutions hold 38.60% stake in the company.
Earnings Estimates
The company has Hims & Hers Health, Inc. analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $5.15, with high estimates of $26.98 and low estimates of $24.74.
EPS for the following year is $Stocks, with Stocks analysts recommending between $ETF and $Stocks.
